NovoCure Ltd

NovoCure Ltd


Market Cap$1.91B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
NovoCure LtdNovoCure Ltd-9.90%-54%4.51.6

Target Price by Analysts

45.2% upsideNovoCure Ltd Target Price DetailsTarget Price

Current Fair Value

93.2% downside

Overvalued by 93.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.91 Billion
Enterprise Value$1.61 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.8
Outstanding Shares107,611,077
Avg 30 Day Volume2,031,633


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-9.89
Price to Sales4.5
Price to Book Ratio5.99
Enterprise Value to Revenue3.06
Enterprise Value to EBIT-7.5
Enterprise Value to Net Income-9
Total Debt to Enterprise0.35
Debt to Equity1.59

Revenue Sources

No data

Insider Trades

ESG Score

No data

About NovoCure Ltd

CEO: Asaf Danziger